Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ
Published January 22, 2020 · Recall initiated: December 26, 2019
Summary
FDA records drug Class II recall D-0659-2020, published January 22, 2020 and initiated December 26, 2019. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 384/100 count bottles; Lot: a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
What to do
Voluntary: Firm initiated · Letter
Get an email if SUMATRIPTAN SUCCINATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SUMATRIPTAN SUCCINATE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Distributor
- Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
- UPC
- 0362756521889
- Lot
- a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals,June 15, 2022
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDCJanuary 22, 2020
- FDASumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only,January 22, 2020
- FDAPanther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging,January 22, 2020
- FDADutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE,January 22, 2020
- FDARhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologramJanuary 22, 2020
Questions about this recall
Was Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ recalled?
Yes. FDA published recall D-0659-2020 on January 22, 2020. Reported hazard: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SUMATRIPTAN SUCCINATE. UPC: 0362756521889.